β adrenergic blockers lower renin in patients treated with ACE inhibitors and diuretics

Heart

Volumn 80, Issue 1, 1998, Pages 45-48

  Holmer, S R ^a   Hense, H W ^b,c   Danser, A H J ^d   Mayer, B ^a   Riegger, G A J ^a   Schunkert, H ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Adrenergic receptor blocker; Angiotensin converting enzyme inhibitor; Hypertension; Renin

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE REGULATION; DIURESIS; DRUG EFFECT; DRUG POTENTIATION; ENZYME INHIBITION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0031827455     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.80.1.45     Document Type: Article

References (21)

1. Davis JO, Freeman RH. Mechanisms regulating renin release. Physiol Rev 1976;56:1 56.
2. Mooser V, Nussberger J, Juillerat L, et al. Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition. J Cardiovasc Phamacol 1990;15:276-82.
3. Van Den Meiracker AH, Man in't Veld AJ, Adrmiraal PJJ, et al. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response? J Hypertens 1992;10:803-12.
4. Azizi M, Chatellie G, Guyene TT, et al. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. Circulation 1995;92:825-34.
5. Henning R, Karlberg BE, Odar-Cederlof I, et al. Timolol and hydrochlorothiazide-amiloride in primary hypertension. Clin Phamacol Ther 1980;28:707-14.
6. Packer M, Bristow MR, Cohn LN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55.
7. Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in dilated cardiomyopathy (MDC) trial study group. Lancet 1993;342:1441-6.
8. CIBIS Investigators and Committees. A randomized trial of β-blockade in heart failure: the cardiac insufficiency bisoprolol study (CIBIS). Circulation 1994;90:1765-73.
9. Schunkert H, Hense H-W, Danser J, et al. Association between circulating components of the renin angiotensin aldosterone system and left ventricular mass. Heart 1997;77:24-31.
10. Schunkert H, Danser J, Hense H-W, et al. Effects of estrogen replacement therapy on the renin angiotensin system in postmenopausal women. Circulation 1997;95:39-45.
11. Derkx FHM, deBruin RJA, vanGool JMG, et al. Clinical validation of renin monoclonal antibody based sandwich assays of renin and prorenin, and use of renin inhibitor to enhance prorenin immunoreactivity. Clinical Chemistry 1996;42:1051-63.
12. Yoneda S, Kako T, Koketsu M, et al. Single administration of captopril and combined use with beta-blocker and/or thiazide diuretic in the treatment of essential hypertension Angiology 1991;42:914-23.
13. Teeuw AH, Leenen FH, Geyskes GG, et al. Atenolol and chlorthalidone on blood pressure, heart rate, and plasma renin activity in hypertension. Clin Pharmacol Ther 1979;25:294-302.
14. Horky K, Gregorova I, Dvorakova J. The effect of renin and aldosterone inhibition by beta-adrenergic blockade on the response to the new diuretic azosemide. Eur J Pharmacol 1981;69:439-46.
15. Eichhorn EJ, McGhie AL, Corbett JR, et al. Effects of bucindolol on neurohumoral activation in congestive heart failure. Am J Cardiol 1991;67:67-73.
16. Holmer S, Rinne B, Eckardt K-U, et al. Role of renal nerves for the expression of renin in adult rat kidney. Am J Physiol 1994;266:F738-45.
17. Tkacs NC, Kim M, Denzon M, et al. Pharmacological evidence for involvement of the sympathetic nervous system in the increase in renin secretion produced by a low sodium diet in rats. Life Sci 1990;47:2317-22.
18. Schunkert H, Ingelfinger JR, Hirsch AT, et al. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ Res 1993;72:312-8.
19. Urata H, Kinoshita A, Misono MS, et al. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 1990;165:22348-57.
20. Dustan HP, Roccella EJ, Garrison HH. Controlling hypertension. A research success story. Arch Intern Med 1996;156:1926-35.
21. Goldstein S. Beta-blockers in hypertensive and coronary heart disease. Arch Intern Med 1996;156:1267-76.